跳至主要内容
临床试验/NCT02127554
NCT02127554已完成不适用

Langzeitresultate Und Komplikationen Nach Einer Epistaxisbehandlung

University of Zurich1 个研究点 分布在 1 个国家目标入组 591 人开始时间: 2014年1月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
591
试验地点
1
主要终点
Number of patients without recurrence

研究概览

简要总结

The aim of this study is to find the most agreeable and in the long term most efficient treatment for epistaxis.

详细描述

In the general population epistaxis occurs quite frequently. Approximately 60% of persons will be affected once in their lifetime, and 6% thereof will seek medical advice. Thereby anterior and posterior epistaxis are discerned. Anterior epistaxis is usually located at the Locus Kisselbachii, while posterior bleeds are found further back in the nose. There, most bleeds will originate from the A. sphenopalatina or the A. ethmoidalis.

Different treatment modalities exist. Anterior epistaxis are usually easier to treat than posterior ones. The aim of this study is to find the most efficient treatment. This involves the assessment of long term results and potential sequelae. Existing data will be complemented with information about recurrences and complications. The question is: Which treatment method leads to the least numbers of recurrences in the long term with the fewest long term sequelae?

Secondly, the most agreeable, least painful treatment method is to be identified. Therefore we will send out questionnaires to patients that were treated between March 29, 2007 and April 1st, 2008 at the Zurich University Hospital.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
14 Years 至 80 Years(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • All patients treated during the study period with known address and who did not decease in the meantime.

排除标准

  • Insufficiently filled out questionnaires; Obvious lack of ability to remember (as tested by control questions); Known mental disability

结局指标

主要结局

Number of patients without recurrence

时间窗: Up to 8 years post-treatment

次要结局

  • Discomfort caused by treatment(Up to 1 day post-treatment)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验